BUSINESS● LOWAug 14 · Aug 14, 2026, 5:47 AM
Eton Pharmaceuticals forecasts 2026 revenue to exceed $145M while targeting adjusted EBITDA margin above 35%
Seeking Alpha Tech
Eton Pharmaceuticals projects its 2026 revenue to surpass $145 million, alongside an adjusted EBITDA margin target exceeding 35%. This outlines the company's financial expectations for the coming years.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Business
BUSINESSnowMunicipal Securities Underwriters Pay a Total of $325,000 in FinesSECBUSINESSnowSEC CHAIRMAN ARTHUR LEVITT, IOWA OFFICIALS TO HOLD INVESTORS’ TOWN MEETING IN DES MOINESSECBUSINESS16m agoN4,000/$ Exchange Rate: NDC asks why refineries are not workingVanguard NigeriaBUSINESS21m agoAt 50: Brand refresh raises questions about heritage, consumer loyaltyVanguard Nigeria